Abstract:An abnormal hormonal activity or exposure to endocrine-disrupting chemicals (EDCs) can cause endocrine system malfunction. Among the many interactions EDCs can affect is the disruption of estrogen signalling, which can lead to adverse health effects such as cancer, osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, and obesity. Knowing which chemical can act as an EDC is a significant advantage and a practical necessity. New Approach Methodologies (NAM) computational models offer a quick and cost-effective solution for preliminary hazard assessment of chemicals without animal testing. Therefore, a machine learning approach was used to investigate the relationships between estrogen receptor (ER) activity and chemical structure to identify chemicals that can interact with ER. For this purpose, the consolidated in vitro assay data from ToxCast/Tox21 projects was used for developing Random Forest classification models for ER binding, agonists, and antagonists. The overall classification prediction accuracy reaches up to 82%, depending on whether the model predicted agonists, antagonists, or compounds that bind to the active site. Given the imbalance in endocrine disruption data, the derived models are good candidates for deprioritising chemicals and reducing animal testing. The interpretation of theoretical molecular descriptors of the models was consistent with the molecular interactions known in the ligand binding pocket. The estimated class probabilities enabled the analysis of the applicability domain of the developed models and the assessment of the predictions' reliability, followed by the guidelines for interpreting prediction results. The models are openly accessible and useable at QsarDB.org (http://dx.doi.org/10.15152/QDB.259) according to the FAIR (Findable, Accessible, Interoperable, Reusable) principles.

Virtual Screening of Potentially Endocrine-Disrupting Chemicals Against Nuclear Receptors and Its Application to Identify PPARγ-bound Fatty Acids

Allosteric binding on nuclear receptors: Insights on screening of non-competitive endocrine-disrupting chemicals

Large-Scale Screening of Per- and Polyfluoroalkyl Substance Binding Interactions and Their Mixtures with Nuclear Receptors

In Vitro and in Silico Assessment of Endocrine Disrupting Effects of Food Contaminants Through Pregnane X Receptor

Prediction of estrogen receptor binding for 58,000 chemicals using an integrated system of a tree-based model with structural alerts.

Computational Models to Predict Endocrine-Disrupting Chemical Binding with Androgen or Oestrogen Receptors.

LASSO-ing Potential Nuclear Receptor Agonists and Antagonists: A New Computational Method for Database Screening

An Integrated "4-Phase" Approach for Setting Endocrine Disruption Screening Priorities--phase I and II Predictions of Estrogen Receptor Binding Affinity

Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials

Structures of Endocrine-Disrupting Chemicals Correlate with the Activation of 12 Classic Nuclear Receptors

ED Profiler: Machine Learning Tool for Screening Potential Endocrine-Disrupting Chemicals

Screening (ant)agonistic activities of xenobiotics on the retinoic acid receptor alpha (RARα) using in vitro and in silico analysis

Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor Agonists

Comparative Computational Screening of Natural-based Partial Agonists for PPARγ Receptor

Prediction of the Interactions of a Large Number of Per- and Poly-Fluoroalkyl Substances with Ten Nuclear Receptors

Screening of Chemicals with Binding Activities of Liver X Receptors from Reclaimed Waters.

A High-Throughput, Computational System to Predict if Environmental Contaminants Can Bind to Human Nuclear Receptors

Identification of androgen receptor antagonists: In vitro investigation and classification methodology for flavonoid

Interpretable machine learning for the identification of estrogen receptor agonists, antagonists, and binders

Screening 800 putative endocrine disrupting chemicals in a representative mammal, bird, and fish using a neurochemical cell-free testing platform

Integration of in silico approaches to determination of endocrine-disrupting perfluorinated chemicals binding potency with steroidogenic acute regulatory protein